A carbapenem molecule, a last resort antibiotic, enters the carbapenemase enzyme (blue arrow), where the crucial beta-lactam structure gets broken down. The ineffective molecule then leaves (orange arrow)
Scientists have used computer simulations to show how bacteria are able to destroy antibiotics – a breakthrough which will help develop drugs which can effectively tackle infections in the future.
Researchers at the University of Bristol focused on the role of enzymes in the bacteria, which split the structure of the antibiotic and stop it working, making the bacteria resistant.
The new findings, published in Chemical Communications, show that it’s possible to test how enzymes react to certain antibiotics.
It’s hoped this insight will help scientists to develop new antibiotics with a much lower risk of resistance, and to choose the best medicines for specific outbreaks.
Using a Nobel Prize-winning technique called QM/MM – quantum mechanics/molecular mechanics simulations – the Bristol research team were able to gain a molecular-level insight into how enzymes called ‘beta-lactamases’ react to antibiotics.
Researchers specifically want to understand the growing resistance to carbapenems, which are known as the ‘last resort’ antibiotics for many bacterial infections and super bugs such as E. coli.
Resistance to carbapenems makes some bacterial infections untreatable, resulting in minor infections becoming very dangerous and potentially deadly.
The Latest on: Antibiotics
via Google News
The Latest on: Antibiotics
- Popeyes Announces Plans To Remove Artificial Ingredients, Antibioticson March 2, 2021 at 6:00 am
Popeyes announced new food quality and sustainability commitments as part of a 5-year plan facilitated by parent company Restaurant Brands International. Those commitments extend from its food to its ...
- Antibiotics Market Size Worth $57.99 Billion By 2028 | CAGR: 4.5%: Grand View Research, Inc.on March 2, 2021 at 2:17 am
The global antibiotics market size is expected to reach USD 57.99 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 4.5% from 2021 to 2028.
- Searching for novel targets for new antibioticson February 28, 2021 at 4:00 pm
Ribosome formation is viewed as a promising potential target for new antibacterial agents. Researchers from Charité - Universitätsmedizin Berlin have gained new insights into this multifaceted process ...
- Global Systemic Antibiotics Market 2020 Scope of Current and Future Industry, SWOT Analysis and Investment Feasibility 2025on February 28, 2021 at 3:02 am
The latest report entitled Global Systemic Antibiotics Market 2020 by Company, Regions, Type and Application, Forecast to 2025 is an in-depth analysis of the global market on the basis of historic ...
- Bacteria use slimy strategy to defeat antibiotics that fight cystic fibrosison February 27, 2021 at 2:47 am
University of Montana researchers and their partners have discovered a slimy strategy used by bacteria to defeat antibiotics and other drugs used to combat infections afflicting people with cystic ...
- Are Antibiotics Causing Anxiety, Depression and Poor Gut Health?on February 26, 2021 at 9:30 am
Antibiotics might seemingly harmless, but we often underestimate how much these everyday medicinal wonders can impact our productivity, success and mental health. I mean, they save lives don't they?
- Doctors treat female UTIs with wrong antibiotics nearly half the time, study findson February 24, 2021 at 7:00 am
Urinary track infections are painful, frustrating and all too frequent in women of all ages (and some men, too). Doctors are prescribing the wrong antibiotics to treat them, as well as giving out too ...
- Many Older Adults Confused About Proper Use of Antibiotics: Pollon February 23, 2021 at 6:02 am
Many older Americans lack knowledge about antibiotics, with some admitting to using leftover medication, a new survey reveals. More than 2,200 adults, aged 50 to 80, were questioned. Nine out of 10 ...
- Three longtime antibiotics could offer alternative to addictive opioid pain relieverson February 22, 2021 at 2:27 pm
Three decades-old antibiotics administered together can block a type of pain triggered by nerve damage in an animal model, UT Southwestern researchers report. The finding, published online today in ...
- Human monoclonal antibodies can act as a substitute for traditional antibioticson February 22, 2021 at 8:59 am
In the course of a new and groundbreaking study, led by Dr, Natalia Freund and the doctoral candidate Avia Waston at the Sackler Medical Faculty, the research group succeeded in isolating monoclonal ...
via Bing News
